August 3, 2009 – Circulatory assist pump maker Thoratec Corp. and small implantable blood pump maker HeartWare International Inc. terminated their merger agreement in response to U.S. Federal Trade Commission’s complaint in the U.S. Federal District Court challenging the proposed acquisition.
July 31, 2009 – Theregen Inc. said its Anginera heart patch, a living three-dimensional engineered human tissue, was used as the foundation for the ”living band-aid for the heart,” as reported recently at the 2009 American Heart Association Cardiovascular Sciences Conference in Las Vegas, NV.
July 31, 2009 – Heart Force Medical Inc. this week received FDA clearance for its digital Ballistocardiograph (dBG), a noninvasive device to assess cardiac performance by measuring and monitoring the mechanical action of the heart.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 31, 2009 – A United Kingdom court has determined Occlutech GmbH’s products do not infringe on AGA Medical Holdings’ patents for atrial septal defects (ASD) and patent foramen ovale (PFO) occlusion devices.
July 31, 2009 – United Therapeutics Corp. said yesterday the FDA approved TYVASO (treprostinil) Inhalation Solution for the treatment of pulmonary arterial hypertension (PAH) using the TYVASO Inhalation System (which includes the Optineb-ir device and accessories).
July 30, 2009 – The Federal Trade Commission today authorized a lawsuit to block Thoratec Corp’s proposed $282 million acquisition of rival HeartWare International Inc., charging that the transaction would substantially reduce competition in the U.S. market for left ventricular devices (LVADs).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 30, 2009 – A new study comparing nephrotoxicity of the iso-osmolar contrast medium iodixanol to low-osmolar contrast media (LOCM) found iodixanol shows no reduction in contrast-induced acute kidney injury (CI-AKI) compared to some agents, which may prompt the ACC and AHA to change their current guidelines.
July 29, 2009 – Medtronic Inc. said earlier this week it has reached a settlement with Abbott Laboratories over intellectual property litigation regarding stent design and stent delivery systems.
July 29, 2009 – CircuLite Inc. said today it was awarded a Fast-Track Phase I-II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to fund the development of a pediatric circulatory assist device based upon CircuLite’s Synergy Pocket Micro-pump.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 29, 2009 – Transoma Medical Inc., manufacturer of Sleuth AT wireless implantable cardiac monitoring system, today announced the first patient enrollment and implant in a long-term study to monitor patients who have been prescribed catheter ablation therapy for atrial fibrillation (AF) at risk of recurrence of AF after the procedure.
July 29, 2009 – The Society of Nuclear Medicine (SNM) and a coalition of eight other organizations have issued a white paper urging Congress to take steps to maintain adequate supplies of molybdenum-99 (Mo-99), a radioactive substance that is the basis for a common medical isotope used in more than 80 percent of all nuclear medicine procedures.
July 28, 2009 – Bioheart Inc. today said the FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 28, 2009 – Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in the United States.
July 28, 2009 – Onset Medical Corporation said today it received CE mark approval to begin marketing the SoloPath Endovascular Access Catheter in the European Union.
July 28, 2009 – The American College of Cardiology (ACC) is taking a leading role in healthcare reform in partnership with patients, lawmakers and payers. The ACC said it is setting a new standard for healthcare delivery, one that centers on increasing the quality of care and ensuring greater patient access and value.